国邦医药

- 605507

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2023  2022  2021  2020  2019  2018  2017 
国邦医药(605507) 利润表
单位:万元
报表日期2023-09-302023-06-302023-03-312022-12-312022-09-30
一、营业总收入405,347.68280,972.02141,016.27572,092.47411,334.86
营业收入405,347.68280,972.02141,016.27572,092.47411,334.86
二、营业总成本347,855.36237,583.90117,988.09466,476.92328,425.45
营业成本305,417.07211,747.37103,490.15414,488.21294,593.99
营业税金及附加2,311.791,649.38803.123,309.342,237.76
销售费用5,385.133,249.171,534.216,415.363,915.01
管理费用22,954.9915,244.827,632.3529,310.9020,927.87
财务费用-4,489.73-4,050.68-157.46-6,801.11-6,755.22
研发费用16,276.119,743.844,685.7319,754.2313,506.03
资产减值损失----------
公允价值变动收益--363.75--455.83--
投资收益467.14-144.45231.421,953.661,906.94
其中:对联营企业和合营企业的投资收益-153.07-28.73-40.88-74.46-87.15
汇兑收益----------
三、营业利润56,397.5841,751.6023,055.06105,287.7884,033.22
加:营业外收入211.7137.7922.6256.2692.86
减:营业外支出654.23498.77214.371,780.101,082.46
其中:非流动资产处置损失----------
四、利润总额55,955.0641,290.6122,863.30103,563.9483,043.61
减:所得税费用7,189.485,604.983,366.1711,501.7310,907.98
五、净利润48,765.5735,685.6419,497.1492,062.2172,135.63
归属于母公司所有者的净利润48,907.3335,747.0819,462.9392,090.4272,106.46
少数股东损益-141.75-61.4434.20-28.2229.16
六、每股收益
基本每股收益(元/股)0.88000.64000.35001.65001.2900
稀释每股收益(元/股)0.88000.64000.35001.65001.2900
七、其他综合收益----------
八、综合收益总额48,765.5735,685.6419,497.1492,062.2172,135.63
归属于母公司所有者的综合收益总额48,907.3335,747.0819,462.9392,090.4272,106.46
归属于少数股东的综合收益总额-141.75-61.4434.20-28.2229.16
下载全部历史数据到excel中 返回页顶